Centers for Disease Control and Prevention (CDC): 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec. 2008, 83: 373-384.
Google Scholar
Fedson DS: The clinical effectiveness of pneumococcal vaccination: a brief review. Vaccine. 1999, 17 (Suppl 1): 85-90. 10.1016/S0264-410X(99)00113-9.
Article
Google Scholar
Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, Adair RK, Clemens JD: The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991, 325: 1453-1460.
Article
CAS
PubMed
Google Scholar
Moberley SA, Holden J, Tatham DP, Andrews RM: Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2008, CD000422-
Google Scholar
Romero-Steiner S, Frasch CE, Carlone G, Fleck RA, Goldblatt D, Nahm MH: Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin Vaccine Immunol. 2006, 13: 165-169. 10.1128/CVI.13.2.165-169.2006.
Article
CAS
PubMed
PubMed Central
Google Scholar
Romero-Steiner S, Musher DM, Cetron MS, Pais LB, Groover JE, Fiore AE, Plikaytis BD, Carlone GM: Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis. 1999, 29: 281-288. 10.1086/520200.
Article
CAS
PubMed
Google Scholar
Sankilampi U, Honkanen PO, Bloigu A, Herva E, Leinonen M: Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. J Infect Dis. 1996, 173: 387-393.
Article
CAS
PubMed
Google Scholar
Rubins JB, Puri AK, Loch J, Charboneau D, MacDonald R, Opstad N, Janoff EN: Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults. J Infect Dis. 1998, 178: 431-440.
Article
CAS
PubMed
Google Scholar
Rubins JB, Alter M, Loch J, Janoff EN: Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination. Infect Immun. 1999, 67: 5979-5984.
CAS
PubMed
PubMed Central
Google Scholar
Concepcion NF, Frasch CE: Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol. 2001, 8: 266-272.
CAS
PubMed
PubMed Central
Google Scholar
Coughlin RT, White AC, Anderson CA, Carlone GM, Klein DL, Treanor J: Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine. 1998, 16: 1761-1767. 10.1016/S0264-410X(98)00139-X.
Article
CAS
PubMed
Google Scholar
Yu X, Sun Y, Frasch C, Concepcion N, Nahm MH: Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic. Clin Diagn Lab Immunol. 1999, 6: 519-524.
CAS
PubMed
PubMed Central
Google Scholar
Wernette CM, Frasch CE, Madore D, Carlone G, Goldblatt D, Plikaytis B, Benjamin W, Quataert SA, Hildreth S, Sikkema DJ, et al: Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol. 2003, 10: 514-519.
CAS
PubMed
PubMed Central
Google Scholar
Schenkein JG, Park S, Nahm MH: Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency. Vaccine. 2008, 26: 5521-5526. 10.1016/j.vaccine.2008.07.071.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim KH, Yu J, Nahm MH: Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies. Clin Diagn Lab Immunol. 2003, 10: 616-621.
CAS
PubMed
PubMed Central
Google Scholar
Romero-Steiner S, Libutti D, Pais LB, Dykes J, Anderson P, Whitin JC, Keyserling HL, Carlone GM: Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol. 1997, 4: 415-422.
CAS
PubMed
PubMed Central
Google Scholar
Weksler ME, Szabo P: The effect of age on the B-cell repertoire. J Clin Immunol. 2000, 20: 240-249. 10.1023/A:1006659401385.
Article
CAS
PubMed
Google Scholar
Kline GH, Hayden TA, Klinman NR: B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J Immunol. 1999, 162: 3342-3349.
CAS
PubMed
Google Scholar
Musher DM, Chapman AJ, Goree A, Jonsson S, Briles D, Baughn RE: Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis. 1986, 154: 245-256.
Article
CAS
PubMed
Google Scholar
Zheng B, Han S, Takahashi Y, Kelsoe G: Immunosenescence and germinal center reaction. Immunol Rev. 1997, 160: 63-77. 10.1111/j.1600-065X.1997.tb01028.x.
Article
CAS
PubMed
Google Scholar
Fedson DS, Musher DM: Pneumococcal Polysaccharide. Vaccines. Edited by: Plotkin SA, Orenstein WA. 2004, Philadelphia: Saunders, 529-588. 4
Google Scholar
Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm MH: Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol. 2007, 45: 1225-1233. 10.1128/JCM.02199-06.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nahm MH, Lin J, Finkelstein JA, Pelton SI: Increase in the Prevalence of the Newly Discovered Pneumococcal Serotype 6C in the Nasopharynx after Introduction of Pneumococcal Conjugate Vaccine. J Infect Dis. 2009, 199: 320-5. 10.1086/596064.
Article
PubMed
PubMed Central
Google Scholar
Park IH, Moore MR, Treanor JJ, Pelton SI, Pilishvili T, Beall B, Shelly MA, Mahon BE, Nahm MH: Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6C. J Infect Dis. 2008, 198: 1818-1822. 10.1086/593339.
Article
PubMed
PubMed Central
Google Scholar
Musher DM, Groover JE, Graviss EA, Baughn RE: The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae. Clin Infect Dis. 1996, 22: 165-167.
Article
CAS
PubMed
Google Scholar
Konradsen HB: Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons. Clin Infect Dis. 1995, 21: 616-620.
Article
CAS
PubMed
Google Scholar
Carson PJ, Nichol KL, O'Brien J, Hilo P, Janoff EN: Immune function and vaccine responses in healthy advanced elderly patients. Arch Intern Med. 2000, 160: 2017-2024. 10.1001/archinte.160.13.2017.
Article
CAS
PubMed
Google Scholar
Burton RL, Nahm MH: Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies. Clin Vaccine Immunol. 2006, 13: 1004-1009. 10.1128/CVI.00112-06.
Article
CAS
PubMed
PubMed Central
Google Scholar
Martinez JE, Clutterbuck EA, Li H, Romero-Steiner S, Carlone GM: Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae. Clin Vaccine Immunol. 2006, 13: 459-466. 10.1128/CVI.13.4.459-466.2006.
Article
CAS
PubMed
PubMed Central
Google Scholar
Romero-Steiner S, Frasch CE, Carlone G, Fleck RA, Goldblatt D, Nahm MH: Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin Vaccine Immunol. 2006, 13: 165-169. 10.1128/CVI.13.2.165-169.2006.
Article
CAS
PubMed
PubMed Central
Google Scholar
Henckaerts I, Durant N, De Grave D, Schuerman L, Poolman J: Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children. Vaccine. 2007, 25: 2518-2527. 10.1016/j.vaccine.2006.09.029.
Article
CAS
PubMed
Google Scholar
Ogilvie I, Khoury AE, Cui Y, Dasbach E, Grabenstein JD, Goetghebeur M: Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: A systematic review of conclusions and assumptions. Vaccine. 2009, 27: 4891-904. 10.1016/j.vaccine.2009.05.061.
Article
PubMed
Google Scholar
Smith KJ, Zimmerman RK, Nowalk MP, Roberts MS: Age, revaccination, and tolerance effects on pneumococcal vaccination strategies in the elderly: A cost-effectiveness analysis. Vaccine. 2009, 27: 3159-3164. 10.1016/j.vaccine.2009.03.059.
Article
PubMed
Google Scholar